Welcome to Chinese Journal of Clinical Pharmacology and Therapeutics,Today is Chinese

Chinese Journal of Clinical Pharmacology and Therapeutics ›› 2024, Vol. 29 ›› Issue (8): 947-954.doi: 10.12092/j.issn.1009-2501.2024.08.012

Previous Articles     Next Articles

Progress on anti-tumor mechanisms of Ganoderma lucidum active ingredients

LV Yujiao1, ZHOU Shuting2, WANG Lina1, SHEN Mingmei1, LIU Yongchao1   

  1. 1 Medical Technology College of Beihua University, Jilin 132013, Jilin, China; 2 Stomatology of Beihua University, Jilin 132013, Jilin, China 
  • Received:2023-11-29 Revised:2024-03-31 Online:2024-08-26 Published:2024-07-17

Abstract:

Malignant tumors are one of the main causes of death from chronic diseases in China, and their incidence and mortality rates show an increasing trend year by year. Advanced non-surgical treatment of malignant tumors is an important means of improving patients' prognosis and enhancing their quality of life. The traditional Chinese medicine Ganoderma lucidum has anti-tumor effects and plays a role in the treatment of many malignant tumors. In this paper, a systematic review of the effects of Ganoderma lucidum active ingredients on tumors has been conducted at home and abroad in the past five years to explore the anti-tumor mechanism of Ganoderma lucidum active ingredients and to lay a theoretical foundation for the application of Ganoderma lucidum active ingredients in clinical practice.

Key words: ganoderma lucidum, ganoderma lucidum polysaccharide, ganoderma lucidum triterpene, ganoderic acid, antitumor

CLC Number: